Iohexol Injection Market, By Application (Computed Tomography (CT) Scans (Body/organ imaging), Angiography and Angiocardiography, Myelography, Arthrography, and Other Applications (e.g., Urography, Hysterosalpingography, ERCP)), By Dosage Forms (Injection and Oral Solution), By Strength (140 mg iodine/mL, 180 mg iodine/mL, 240 mg iodine/mL, 300 mg iodine/mL, 350 mg iodine/mL, 9 mg iodine/mL, and 12 mg iodine/mL), By Route of Administration (Intrathecal, Intra-arterial, Intravenous, Oral, Rectal, and Intraarticular By Age Group: Adults and Pediatric), By End User (Hospitals and Specialty Clinics, Diagnostic Centers, Imaging Centers, Ambulatory Surgical Centers, and Others (Research and Academic Institutes)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)